CHFR promoter CpG island methylation and subsequent transcriptional silencing was first described in esophageal cancer [46], of which 16.3 % (7/43) was hypermethylated while this was absent in adjacent normal tissues. The gene discussed is CHFR; the disease is esophageal cancer.